semaglutide cardiovascular news HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of death, heart attack, stroke, heart failure, AND ALL CAUSE MORTALITY! Groundbreaking SELECT Cardiovascular risk reduction with once-weekly

If a patient reports new ED after starting a GLP-1 RA, it is worth evaluating other factors (changes in weight, blood pressure, medication interactions, psychological factors, etc.)

To address this, we developed a chimeric GLP-1A that targets transporter-mediated endocytosis to enhance cellular permeability to GLP-1A by utilizing the transporters available in the intestine, particularly the apical sodium-dependent bile acid transporter (ASBT)

Prior authorization necessitates proof of medical necessity before insurers approve coverage

MOTS-c (10 mg) is a mitochondria-derived peptide that activates AMPK, regulates nuclear gene expression under metabolic stress, and enhances insulin sensitivity [4][5][6]

It establishes your history of effort

Influence of cisapride on gastric tone and on the perception of gastric distension